차이
문서의 선택한 두 판 사이의 차이를 보여줍니다.
| 양쪽 이전 판이전 판다음 판 | 이전 판 | ||
| med:preeclampsia_aspirin [2018/12/09 01:54] – [효과] V_L | med:preeclampsia_aspirin [2025/10/30 00:39] (현재) – [임신중독증 저용량아스피린] V_L | ||
|---|---|---|---|
| 줄 1: | 줄 1: | ||
| - | {{tag>low dose aspirin | + | {{tag>BASA preeclampsia}} |
| {{page>: | {{page>: | ||
| ====== 임신중독증 저용량아스피린 ====== | ====== 임신중독증 저용량아스피린 ====== | ||
| | | ||
| 예방을 위한 | 예방을 위한 | ||
| - | //저용량 | + | //[[aspirin|저용량 아스피린 |
| =====효과===== | =====효과===== | ||
| 줄 21: | 줄 21: | ||
| * [[med: | * [[med: | ||
| * [[med: | * [[med: | ||
| - | * [[med:고혈압|만성 고혈압]] | + | * [[med:hypertension|만성 고혈압]] |
| - | * [[med:당뇨병|]] (1형 혹은 2형) | + | * [[med:diabetes_mellitus]] (1형 혹은 2형) |
| * 신장질환 (Renal disease) | * 신장질환 (Renal disease) | ||
| * 자가면역질환 (Autoimmune disease) ([[med: | * 자가면역질환 (Autoimmune disease) ([[med: | ||
| 줄 40: | 줄 40: | ||
| =====안전성===== | =====안전성===== | ||
| - | No increase in infant loss, growth problems, or cognition harm to the baby; | + | - 영아사망, 성장저하, 인지기능저하에 증가가 없다. |
| - | No statistically significant impact on risk of placental abruptions, postpartum hemorrhage (bleeding), or miscarriage to the mother; | + | - 태반박리, 산후출혈, 유산에 통계적으로 중대한 영향이 없다. |
| - | No differences in developmental outcomes of the infants up to age 18 months. | + | |
| + | |||
| + | (( No increase in infant loss, growth problem s, or cognition harm to the baby; | ||
| + | No statistically significant impact on risk of placental abruptions, postpartum hemorrhage (bleeding), or miscarriage to the mother; | ||
| + | No differences in developmental outcomes of the infants up to age 18 months.)) | ||
| =====복용시작시기===== | =====복용시작시기===== | ||
| 줄 49: | 줄 53: | ||
| =====중단시기===== | =====중단시기===== | ||
| - | When should I stop taking low-dose aspirin? | + | |
| - | It is very important that you ask your doctor when you should stop taking aspirin, as recommendations may be differ depending on your medical history. | + | 논란이 있다. |
| - | + | 36주 이후에는 분만가능성이 있고, 아스피린 복용시 출혈가능성이 증가하여 36주까지만 먹어야 한다는 의견과, 36주 이후에 [[med: | |
| - | There are opposing arguments regarding when to discontinue aspirin treatment. Some argue that aspirin should be discontinued at 36 weeks because of the possible bleeding risks associated with delivery. | + | ((There are opposing arguments regarding when to discontinue aspirin treatment. Some argue that aspirin should be discontinued at 36 weeks because of the possible bleeding risks associated with delivery. |
| - | Others argue, because most preeclampsia occurs after 36 weeks, that the aspirin may be beneficial to continue through delivery, into the postpartum period. | + | Others argue, because most preeclampsia occurs after 36 weeks, that the aspirin may be beneficial to continue through delivery, into the postpartum period)) |
| - | More research is needed, but again, it is imperative you discuss a stopping point with your healthcare professional if you are on a prenatal aspirin regimen. | ||
| {{: | {{: | ||
| https:// | https:// | ||